The salivary component of Sjogren's syndrome (SS) is defined as xerostomia
(dry mouth). However, xerostomia is a common symptom associated with quanti
tative and qualitative changes in saliva, which are generally referred to a
s salivary hypofunction. This can be caused by various systemic diseases (i
ncluding SS), anticholinergic effects of many drugs, psychological conditio
ns, and physiological changes. Chronic salivary hypofunction is clinically
significant because it can cause oral dysfunction, dental destruction, and
mucosal infection. Evaluating patients complaining of xerostomia requires p
articular attention to their current medications and physical examination o
f the major salivary glands, teeth, and oral mucosa. Based on that informat
ion and the differential diagnosis of salivary hypofunction, appropriate te
sts can then be selected to develop a final diagnosis. Effective treatment
of patients with chronic salivary hypofunction requires a combination of: (
1) ongoing dental decay prevention and treatment supervised by their dentis
t; (2) salivary flow stimulation; (3) recognition and treatment of chronic
oral candidiasis; (4) selective use of saliva substitutes; and (5) prescrip
tion drug review.